SCHEMBL22497218

SCHEMBL22497218

CC(O)Cn1cc(S(N)(=O)=O)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.35
AURKA O14965 5/20 0.34
AURKB Q96GD4 5/20 0.34
JAK1 P23458 3/20 0.34
CA2 P00918 5/20 0.34
CA9 Q16790 3/20 0.34
CA1 P00915 2/20 0.34
CA7 P43166 2/20 0.34
CA5A P35218 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
ROCK1 Q13464 1/20 0.34
TTK P33981 1/20 0.33
MAPK8 P45983 1/20 0.33
CA4 P22748 1/20 0.33
JAK2 O60674 2/20 0.33
TYK2 P29597 2/20 0.33
JAK3 P52333 2/20 0.33
APLNR P35414 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22497216 1.00 ACHE (0.38) ACHEKMT2AALDH1A1AURKAAURKB
SCHEMBL23851009 0.80 ACHE (0.36) ACHEKMT2AALDH1A1CA2CA9
SCHEMBL17795668 0.78 KMT2A (0.58) KMT2AALDH1A1CA2CA9CA1
SCHEMBL30376243 0.75 L3MBTL1 (0.49) KMT2AALDH1A1CA2
SCHEMBL22497185 0.74 FFAR1 (0.46) KMT2AAURKAAURKBJAK1CA2
SCHEMBL15894907 0.74 ACHE (0.42) ACHEKMT2AALDH1A1JAK1ROCK1
SCHEMBL1662568 0.74 ACHE (0.42) ACHEKMT2AALDH1A1JAK1ROCK1
SCHEMBL1703536 0.74 ACHE (0.42) ACHEKMT2AALDH1A1JAK1ROCK1
SCHEMBL30961719 0.72 ACHE (0.53) ACHEJAK1ROCK1JAK2TYK2
SCHEMBL30702223 0.72 ACHE (0.53) ACHEJAK1ROCK1JAK2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12012392-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2024-06-18 US disclosed
US-20200317637-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2020-10-08 US disclosed
CN-111315733-A Novel sulfonamide carboxamide compounds 英夫拉索姆有限公司 2020-06-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200317637-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS NLRP3, NOD1, PYCARD ACHE 4007/4885KMT2A 2404/4885ALDH1A1 1407/4885
US-12012392-B2 Sulfonamide carboxamide compounds NLRP3, PYCARD, NOD1 ACHE 3501/4885KMT2A 2061/4885ALDH1A1 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.